BEHANDLUNG VON PNEUMONIE

European patent · EP3781172 · In force

Register entry

Publication number
EP3781172
Application number
EP19716950
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 16, 2019
Published
Feb 24, 2021
Granted
Aug 30, 2023
Protection ends at the latest
Apr 15, 2039
Next annual fee due
Apr 30, 2027
IPC classes
A61K 31/575 (2006.01)
A61K 31/688 (2006.01)
A61P 39/00 (2006.01)
A61P 11/00 (2006.01)
A61K 45/06 (2006.01)
A61K 9/00 (2006.01)
A61K 9/127 (2006.01)
Priority
EP 18167848 17.04.2018
PCT application
PCT/EP2019/059826 16.04.2019
PCT publication
WO2019/201937 24.10.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. Jul 10, 2024

    Change

    Published in Swissreg on 10.07.2024

  4. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  5. Sep 29, 2023

    Agent entered

    Representative
    Latscha Schöllhorn Partner AG, Grellingerstrasse 60, 4052 Basel

    Published in Swissreg on 29.09.2023

  6. Aug 30, 2023

    Granted

    Published in Swissreg on 30.08.2023

Parties

Holder

Combioxin SA

8 Route de la Corniche, 1066 Epalinges

Agent

Latscha Schöllhorn Partner AG

Grellingerstrasse 60, 4052 Basel

Inventor

LAJAUNIAS, Frédéric

1206 Geneva

AZEREDO DA SILVEIRA LAJAUNIAS, Samareh

1206 Geneva

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.